PKC
AVNS

Palmer Knight Company’s Avanos Medical AVNS Stock Holding History

Palmer Knight Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-66,303
Closed -$1.95M – 25
2020
Q2 		$1.95M Sell
66,303
-5,068
-7% -$147K 1.52% 25
2020
Q1 		$1.92M Sell
71,371
-13,205
-16% -$394K 1.85% 25
2019
Q4 		$2.85M Buy
84,576
+31
+0% +$1.12K 2.38% 22
2019
Q3 		$3.17M Buy
84,545
+1,903
+2% +$72.6K 2.69% 22
2019
Q2 		$3.6M Buy
82,642
+2,890
+4% +$124K 3.11% 21
2019
Q1 		$3.4M Buy
79,752
+2,042
+3% +$91.4K 3.15% 21
2018
Q4 		$3.48M Buy
+77,710
New +$4.07M 4.08% 18

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Palmer Knight Company's AVNS Position: Q3 2020 in Review

Palmer Knight Company sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 66,303 shares — an estimated $1.95M sold.

Palmer Knight Company first reported a position in AVNS in Q4 2018 and held it in 7 quarters. The position peaked at $3.6M in Q2 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Palmer Knight Company reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Palmer Knight Company sold 66,303 Avanos Medical shares in Q3 2020, an estimated $1.95M.
  • Palmer Knight Company first reported a position in Avanos Medical in Q4 2018 and held it in 7 quarters.
  • Palmer Knight Company's Avanos Medical position peaked at $3.6M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Palmer Knight Company's 13F filing for Q3 2020, filed 29 Oct 2020.